Aptevo Therapeutics Inc (APVO)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | Marvin L. White |
Employees: | 50 |
Web site: | aptevotherapeutics.com |
2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
206-838-0500
|
Date | Ratio |
---|---|
2020-03-27 | 1:14 |
2024-03-06 | 1:44 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Aptevo Therapeutics Inc. focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company also has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527.
Please log in first to see chart